Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.

This invention relates to polymers comprising: one or more that include 1) at least 11 wt % 4 substituted 1,4 hexadiene and less than 20 wt % 5-methyl-1,4-hexadiene, based upon the weight of the polymer, and 2) optionally, one or more olefins; and processes to produces such polymers using metallocene or post-metallocene catalyst compounds.

This invention relates to polymers comprising: one or more that include 1) at least 11 wt % 4 substituted 1,4 hexadiene and less than 20 wt % 5-methyl-1,4-hexadiene, based upon the weight of the polymer, and 2) optionally, one or more olefins; and processes to produces such polymers using metallocene or post-metallocene catalyst compounds.

A fluorine-containing polymer has a fluorine content of 50% by mass or more, a degree of unsaturation of 0.1 mEq/g or more, and a glass transition temperature of 20 C. or higher, and the relationship between the maximum value E*1 of the complex elastic modulus in the range of from 50 C. to (glass transition temperature 10 C.) and the minimum value E*2 of the complex elastic modulus in the range of from (glass transition temperature +10 C.) to 250 C. satisfies the following inequality: E*2/E*10.01.

A fluorine-containing polymer has a fluorine content of 50% by mass or more, a degree of unsaturation of 0.1 mEq/g or more, and a glass transition temperature of 20 C. or higher, and the relationship between the maximum value E*1 of the complex elastic modulus in the range of from 50 C. to (glass transition temperature 10 C.) and the minimum value E*2 of the complex elastic modulus in the range of from (glass transition temperature +10 C.) to 250 C. satisfies the following inequality: E*2/E*10.01.

Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.

Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.

Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.

Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.